Annual Accounts Payable
$3.78 M
-$4.29 M-53.12%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual accounts payable is currently $3.78 million, with the most recent change of -$4.29 million (-53.12%) on 31 December 2023. During the last 3 years, it has fallen by -$816.00 thousand (-17.75%). TNXP annual accounts payable is now -71.53% below its all-time high of $13.28 million, reached on 31 December 2021.TNXP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.94 M
-$6.47 M-62.19%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly accounts payable is currently $3.94 million, with the most recent change of -$6.47 million (-62.19%) on 30 September 2024. Over the past year, it has dropped by -$3.86 million (-49.54%). TNXP quarterly accounts payable is now -70.37% below its all-time high of $13.28 million, reached on 31 December 2021.TNXP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.1% | -49.5% |
| 3 y3 years | -17.8% | -50.6% |
| 5 y5 years | +169.4% | +251.7% |
TNXP Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -71.5% | at low | -70.4% | +4.0% |
| 5 y | 5 years | -71.5% | +169.4% | -70.4% | +251.7% |
| alltime | all time | -71.5% | -70.4% |
Tonix Pharmaceuticals Holding Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.94 M(-62.2%) |
| June 2024 | - | $10.41 M(+56.5%) |
| Mar 2024 | - | $6.65 M(+75.8%) |
| Dec 2023 | $3.78 M(-53.1%) | $3.78 M(-51.5%) |
| Sept 2023 | - | $7.80 M(+1.6%) |
| June 2023 | - | $7.67 M(-4.3%) |
| Mar 2023 | - | $8.02 M(-0.6%) |
| Dec 2022 | $8.07 M(-39.3%) | $8.07 M(+77.1%) |
| Sept 2022 | - | $4.56 M(-52.4%) |
| June 2022 | - | $9.57 M(+1.8%) |
| Mar 2022 | - | $9.40 M(-29.3%) |
| Dec 2021 | $13.28 M(+188.9%) | $13.28 M(+66.8%) |
| Sept 2021 | - | $7.96 M(+133.8%) |
| June 2021 | - | $3.41 M(+19.1%) |
| Mar 2021 | - | $2.86 M(-37.8%) |
| Dec 2020 | $4.60 M(+49.8%) | $4.60 M(+159.8%) |
| Sept 2020 | - | $1.77 M(-44.5%) |
| June 2020 | - | $3.19 M(+126.5%) |
| Mar 2020 | - | $1.41 M(-54.1%) |
| Dec 2019 | $3.07 M(+118.7%) | $3.07 M(+174.4%) |
| Sept 2019 | - | $1.12 M(+7.2%) |
| June 2019 | - | $1.04 M(-7.9%) |
| Mar 2019 | - | $1.13 M(-19.3%) |
| Dec 2018 | $1.40 M(+8.3%) | $1.40 M(+33.6%) |
| Sept 2018 | - | $1.05 M(-35.9%) |
| June 2018 | - | $1.64 M(+29.7%) |
| Mar 2018 | - | $1.26 M(-2.5%) |
| Dec 2017 | $1.30 M(+48.6%) | $1.30 M(-4.8%) |
| Sept 2017 | - | $1.36 M(+15.5%) |
| June 2017 | - | $1.18 M(+40.2%) |
| Mar 2017 | - | $841.00 K(-3.6%) |
| Dec 2016 | $872.00 K | $872.00 K(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | $944.00 K(-51.2%) |
| June 2016 | - | $1.94 M(-6.4%) |
| Mar 2016 | - | $2.07 M(-32.2%) |
| Dec 2015 | $3.05 M(+105.0%) | $3.05 M(+25.9%) |
| Sept 2015 | - | $2.42 M(-12.6%) |
| June 2015 | - | $2.77 M(+39.5%) |
| Mar 2015 | - | $1.99 M(+33.6%) |
| Dec 2014 | $1.49 M(+94.4%) | $1.49 M(-39.3%) |
| Sept 2014 | - | $2.45 M(+61.3%) |
| June 2014 | - | $1.52 M(+8.5%) |
| Mar 2014 | - | $1.40 M(+82.9%) |
| Dec 2013 | $765.00 K(-7.3%) | $765.00 K(-22.4%) |
| Sept 2013 | - | $985.80 K(-32.5%) |
| June 2013 | - | $1.46 M(+67.9%) |
| Mar 2013 | - | $870.10 K(+5.5%) |
| Dec 2012 | $825.00 K(+18.7%) | $825.00 K(+18.3%) |
| Sept 2012 | - | $697.40 K(+43.2%) |
| June 2012 | - | $486.90 K(+166.9%) |
| Mar 2012 | - | $182.40 K(-73.8%) |
| Dec 2011 | $695.20 K(+118.8%) | $695.20 K(>+9900.0%) |
| Sept 2011 | - | $5200.00(+48.6%) |
| June 2011 | - | $3500.00(+34.6%) |
| Mar 2011 | - | $2600.00(-99.2%) |
| Dec 2010 | $317.70 K(>+9900.0%) | $317.70 K(>+9900.0%) |
| Sept 2010 | - | $1900.00(+533.3%) |
| June 2010 | - | $300.00(0.0%) |
| Mar 2010 | - | $300.00(-70.0%) |
| Dec 2009 | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Dec 2008 | $0.00 | $0.00(-100.0%) |
| Sept 2008 | - | $43.00 K(+93.7%) |
| June 2008 | - | $22.20 K(>+9900.0%) |
| Mar 2008 | - | $0.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual accounts payable?
- What is the all time high annual accounts payable for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual accounts payable year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly accounts payable?
- What is the all time high quarterly accounts payable for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly accounts payable year-on-year change?
What is Tonix Pharmaceuticals Holding annual accounts payable?
The current annual accounts payable of TNXP is $3.78 M
What is the all time high annual accounts payable for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual accounts payable is $13.28 M
What is Tonix Pharmaceuticals Holding annual accounts payable year-on-year change?
Over the past year, TNXP annual accounts payable has changed by -$4.29 M (-53.12%)
What is Tonix Pharmaceuticals Holding quarterly accounts payable?
The current quarterly accounts payable of TNXP is $3.94 M
What is the all time high quarterly accounts payable for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly accounts payable is $13.28 M
What is Tonix Pharmaceuticals Holding quarterly accounts payable year-on-year change?
Over the past year, TNXP quarterly accounts payable has changed by -$3.86 M (-49.54%)